Pierre A. MORGON is CEO of MRGN Advisors, Chief Business Officer at Nuvamid, Co-Founder and interim CEO at Ibex Therapeutics.

He also holds several board positions in private and public emerging companies and non-profit organizations.

Pierre has over 35 years of experience in the global life science industry, in C-level positions at global level in multinational corporations and as CEO of start-up companies. 

He is a mentor for start-up life sciences companies at Mass Challenge Switzerland and Israel.

He holds a Doctorate of Pharmacy, a Master in Business Law and a MBA, and he is an alumnus of INSEAD and IMD.